We are live on ! Find out more
VV

Verity & Verity Portfolio holdings

AUM $1.34B
1-Year Est. Return 18.66%
This Fund
S&P 500
This Quarter Est. Return
+6.93%
1 Year Est. Return
+18.66%
3 Year Est. Return
+55.97%
5 Year Est. Return
+76.97%
10 Year Est. Return
+236.01%
AUM
$1.25B
AUM Growth
+$86.1M
Cap. Flow
+$18.3M
Cap. Flow %
1.47%
Top 10 Hldgs %
30.64%
Holding
139
New
6
Increased
58
Reduced
51
Closed
5

Top Buys

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$22.4M
2
ACN icon
Accenture
ACN
+$14.9M
3
CNI icon
Canadian National Railway
CNI
+$5.93M
4
PLD icon
Prologis
PLD
+$5.45M
5
DIVZ icon
Polen Dividend Income ETF
DIVZ
+$4.91M

Top Sells

Rank Stock Value
1
PPH icon
VanEck Pharmaceutical ETF
PPH
+$11.6M
2
TFC icon
Truist Financial
TFC
+$10M
3
HSY icon
Hershey
HSY
+$9.31M
4
OGE icon
OGE Energy
OGE
+$8.97M
5
OWL icon
Blue Owl Capital
OWL
+$4.65M

Sector Composition

Rank Sector Weight
1 Technology 22.35%
2 Financials 17.35%
3 Healthcare 14.67%
4 Energy 10.71%
5 Industrials 8.35%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AVGO icon
1
Broadcom
AVGO
$1.82T
$69.4M 5.55%
210,258
-3,025
-1% -$928K
ABBV icon
2
AbbVie
ABBV
$458B
$40.1M 3.21%
173,375
+1,181
+0.7% +$240K
MSFT icon
3
Microsoft
MSFT
$2.84T
$39.3M 3.14%
75,816
-285
-0.4% -$145K
JPM icon
4
JPMorgan Chase
JPM
$939B
$39.1M 3.13%
124,042
+2
+0% +$595
RTX icon
5
RTX Corp
RTX
$287B
$35.8M 2.86%
213,796
-23,197
-10% -$3.6M
CVX icon
6
Chevron
CVX
$388B
$33.4M 2.67%
215,112
+1,725
+0.8% +$267K
PFE icon
7
Pfizer
PFE
$140B
$32.7M 2.62%
1,284,258
+907,855
+241% +$22.4M
AAPL icon
8
Apple
AAPL
$4.89T
$31.8M 2.54%
124,705
+794
+0.6% +$179K
STT icon
9
State Street
STT
$50.9B
$31.2M 2.5%
269,037
+1,268
+0.5% +$142K
GILD icon
10
Gilead Sciences
GILD
$161B
$30M 2.4%
270,699
-13,079
-5% -$1.49M
PEP icon
11
PepsiCo
PEP
$186B
$29.3M 2.34%
208,346
+3,462
+2% +$494K
AMGN icon
12
Amgen
AMGN
$203B
$28.4M 2.27%
100,518
+3,438
+4% +$997K
ENB icon
13
Enbridge
ENB
$124B
$28M 2.24%
555,807
+5,826
+1% +$274K
GLW icon
14
Corning
GLW
$126B
$26.6M 2.13%
324,199
-790
-0.2% -$51.6K
VZ icon
15
Verizon
VZ
$194B
$23.4M 1.87%
532,974
+3,535
+0.7% +$153K
NEE icon
16
NextEra Energy
NEE
$187B
$21.4M 1.71%
283,426
+3,633
+1% +$265K
JNJ icon
17
Johnson & Johnson
JNJ
$635B
$21.3M 1.71%
114,923
+1,441
+1% +$247K
TXN icon
18
Texas Instruments
TXN
$255B
$20.8M 1.66%
113,177
+1,641
+1% +$321K
MO icon
19
Altria Group
MO
$122B
$20.4M 1.63%
308,823
+2,220
+0.7% +$141K
PRU icon
20
Prudential Financial
PRU
$41.7B
$20.2M 1.62%
195,060
+6,040
+3% +$636K
MET icon
21
MetLife
MET
$61B
$20.1M 1.61%
244,027
+4,203
+2% +$331K
OKE icon
22
Oneok
OKE
$58.7B
$19.5M 1.56%
267,434
-13,246
-5% -$1.01M
CSCO icon
23
Cisco
CSCO
$450B
$19.5M 1.56%
284,800
+1,905
+0.7% +$130K
DELL icon
24
Dell
DELL
$283B
$19.2M 1.53%
135,195
+4,606
+4% +$598K
NNN icon
25
NNN REIT
NNN
$9.39B
$19.1M 1.53%
448,908
+4,221
+0.9% +$179K

Similar funds

Verity & Verity's Q3 2025 Portfolio in Review

As of Q3 2025, Verity & Verity held 139 positions worth $1.25B, up 7.4% from $1.16B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Verity & Verity's Q3 2025 filing shows 6 new, 58 increased, 51 reduced and 5 closed positions. Its largest new stake was Polen Dividend Income ETF: 136,886 shares worth $4.98M. The largest sale was VanEck Pharmaceutical ETF, an estimated $11.6M.

By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 20% a quarter earlier, followed by Financials and Healthcare.

  • Verity & Verity's largest Q3 2025 buy was Polen Dividend Income ETF: 136,886 shares worth $4.98M.
  • Verity & Verity added most to Pfizer in Q3 2025, an estimated $22.4M increase.
  • Verity & Verity's biggest Q3 2025 reduction was Truist Financial, cutting an estimated $10M.
  • Verity & Verity fully exited VanEck Pharmaceutical ETF in Q3 2025, selling an estimated $11.6M.
  • Verity & Verity's ten largest holdings make up 31% of its $1.25B portfolio in Q3 2025.
  • Verity & Verity opened 6 new positions and closed 5 in Q3 2025.
  • Verity & Verity's portfolio value rose 7.4% quarter-over-quarter to $1.25B.

Based on Verity & Verity's 13F filing for Q3 2025, filed 21 Oct 2025.